Showing results (111-120 of 2,902) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|March 18, 2006
Effects of hypoxia and limited diffusion in tumor cell microenvironment on bystander effect of P450 prodrug therapyM Günther, D J Waxman, E Wagner, et al.Cancer Gene Therapy|March 18, 2006
Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice modelD-E Zhu, N Höti, Z Song, et al.Cancer Gene Therapy|March 18, 2006
FasL gene therapy: a new therapeutic modality for head and neck cancerS ElOjeimy, J C McKillop, A M El-Zawahry, et al.Cancer Gene Therapy|March 18, 2006
The rationale for prophylactic cancer vaccines and need for a paradigm shiftR E SobolCancer Gene Therapy|February 18, 2006
Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancerK Naruishi, T L Timme, N Kusaka, et al.Cancer Gene Therapy|February 22, 2002
Connexin 43-mediated bystander effect in two rat glioma cell modelsMarc Sanson, Véronique Marcaud, Eric Robin, et al.Cancer Gene Therapy|November 21, 1998
Functional analysis of Ran/TC4 as a protein regulating T-cell costimulationJ D Nieland, M C Haks, B L Kremers, et al.Cancer Gene Therapy|November 21, 1998
Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanomaJ Nemunaitis, C Bohart, T Fong, et al.Cancer Gene Therapy|November 21, 1998
Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoterF Mawatari, S Tsuruta, A Ido, et al.Cancer Gene Therapy|November 21, 1998
Use of a tissue-specific promoter for targeted expression of the herpes simplex virus thymidine kinase gene in cervical carcinoma cellsM W Robertson, M Wang, G P Siegal, et al.Pageof 291